Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: A case series

Journal of ECT

Volumn 21, Issue 1, 2005, Pages 31-34

  Britto De Macedo Soares, Marcia ^a   Moreno, Ricardo A ^a   Rigonatti, Sergio P ^a   Lafer, Beny ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Electroconvulsive therapy; Treatment resistance

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MALE; PSYCHOSIS; RATING SCALE; THERAPY RESISTANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; TREATMENT FAILURE;

EID: 16344363600     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yct.0000148621.88104.f1     Document Type: Article

References (31)

1. American Psychiatric Association. Practice Guideline for Treatment of Patients With Bipolar Disorder. Washington DC: American Psychiatric Association; 1995.
2. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry. 1994;151:169-176.
3. Devanand DP, Polanco P, Cruz R, et al. The efficacy of ECT in mixed affective states. J ECT. 2000;16:32-37.
4. Gruber NP, Dilsaver SC, Shoaib AM, et al. ECT in mixed affective states: a case series. J ECT. 2000;16:183-188.
5. Mukherjee S, Sackeim HA, Lee C. Unilateral ECT in the treatment of manic episodes. Convuls Ther. 1988;4:74-80.
6. Cole AJ, Scott J, Ferrier IN, et al. Patterns of treatment resistance in bipolar disorder. Acta Psychiatr Scand. 1993;88:121-123.
7. Sharma V, Mazmanian D, Persad E, et al. A comparison of comorbid patterns in treatment-resistant unipolar and bipolar depression. Can J Psychiatry. 1995;40:270-274.
8. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment refractory mania. Am J Psychiatry. 1996;153:759-764.
9. Sachs GS. Treatment-resistant bipolar depression. Psychiatry Clin North Am. 1996;19:215-236.
10. Folkerts HW, Michael N, Tölle R, et al. Electroconvulsive therapy vs. Paroxetine in treatment resistant depression - a randomized study. Acta Psychiatry Scand. 1997;96:334-342.
11. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 1997;72:145-148.
12. Altshuler LL, Keck PE, McElroy SL, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord. 1999;1:61-65.
13. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV axis I disorders - patient edition (version 2.0, 8/98 revision). New York. Biometrics Research Department. 1998;99:9-99.
14. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56.
16. Pricoli V, Vasconcelos AAJ, Rigonatti SP, et al. Exames complementares pré-eletroconvulsoterapia. Rev Psiq Clin. 1996;23:69-71.
17. Overall JF, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;799-812.
18. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159-171.
19. th. Edition (DSM-IV). Washington DC: American Psychiatric Association; 1994.
20. Macedo-Soares MB, Camargo APP, Moreno RA. Eletroconvulsoterapia: crenças, percepções e observações clínicas. In Congresso Brasileiro de Psiquiatria, 18°., Livro de Resumos. Associação Brasileira de Psiquiatria; 2000:183.
21. Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berl). 1989;98:535-538.
22. Maj M. Lithium prophylaxis of bipolar disorder in ordinary clinical conditions: patterns of long-term outcome. In: Goldberg JF, Harrow M eds. Bipolar Disorders: Clinical Course and Outcome. Washington, DC: American Psychiatric Press; 1999:21-37.
23. Sonne SC, Brady KT. Substance abuse and bipolar comorbidity. Psychiatry Clin North Am. 1999;22:609-627.
24. Strakowski SM, Delbello MP. The Co-occurrence of bipolar and substance disorders. Clin Psychol Rev. 2000;20:191-206.
25. Hatterer JA, Kocsis JH, Stokes PE. Thyroid function in patients maintained on lithium. Psychiatry Res. 1988;26:249-257.
26. Baumgartner A, Von Stuckrad M, Müller-Oerlinghausen B, et al. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to prophylactic efficacy. J Affect Disord. 1995;34:211-218.
27. Kleiner J, Altshuler L, Hendrick V, et al. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry. 1999;60:249-255.
28. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive therapy compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988;45:727-732.
29. Schnur DB, Mukherjee S, Sackeim HA, et al. Symptomatic predictors of response in medication non-responsive manic patients. J Clin Psychiatry. 1992;53:63-66.
30. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992;149:1633-1644.
31. Srisurapanont M, Yatham LN, Zis AP. Treatment of acute bipolar depression: a review of the literature. Can J Psychiatry. 1995;40:533-544.